Alar Pharmaceuticals Inc. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Alar Pharmaceuticals Inc. (6785.TWO) is 25.01

According to Alar Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 25.01. This represents a change of -13.22% compared to the average of 28.82 of the last 4 quarters.

Alar Pharmaceuticals Inc. (6785.TWO) Historical Current Ratio (quarterly & annually)

How has 6785.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Alar Pharmaceuticals Inc. over the last ten years is 147.66. The current 25.01 Current Ratio has changed 1.59% with respect to the historical average. Over the past ten years (40 quarters), 6785.TWO's Current Ratio was at its highest in in the September 2024 quarter at 45.14. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Alar Pharmaceuticals Inc. (6785.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alar Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alar Pharmaceuticals Inc. (6785.TWO) Average Current Ratio

How has 6785.TWO Current Ratio performed in the past?

The current Current Ratio of Alar Pharmaceuticals Inc. (6785.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alar Pharmaceuticals Inc. (6785.TWO) Current Ratio vs. Peers

How is 6785.TWO’s Current Ratio compared to its peers?

Alar Pharmaceuticals Inc.’s Current Ratio is greater than Grape King Bio Ltd (1.60), greater than Handa Pharmaceuticals, Inc. (8.91), greater than Synmosa Biopharma Corporation (2.60), greater than TTY Biopharm Company Limited (1.71), greater than YungShin Global Holding Corporation (2.50), greater than Foresee Pharmaceuticals Co., Ltd. (13.61), greater than ScinoPharm Taiwan, Ltd. (6.55), greater than TaiMed Biologics Inc. (16.83), less than EirGenix Inc. (0), greater than Great Tree Pharmacy Co., Ltd. (1.48),

Build a custom stock screener for Alar Pharmaceuticals Inc. (6785.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alar Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alar Pharmaceuticals Inc. (6785.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alar Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.